Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device Sector Expected To Gain The Most From China’s Healthcare Reform

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI- China's medical device market has reached RMB 83 billion ($12.1 billion), roughly one-eighth of the total healthcare industry, according to a report by Frost & Sullivan

You may also be interested in...



China Unveils Latest Five-Year Plans For Pharma And Medical Device Industries (Part 1 of 2)

China’s ambitious five-year plans will support policies to increase domestic R&D and import substitution for China’s biopharma and medical device industries.

China Releases New Policies To Welcome More Foreign Investment

SHANGHAI - China's State Council released April 13 new guidelines that allow more foreign investment in China that promise a better environment for overseas investment, drawing some relief for industry associations that consider recent policy moves as protectionist and that they say stifle cross-border innovation

China Releases New Policies To Welcome More Foreign Investment

SHANGHAI - China's State Council released April 13 new guidelines that allow more foreign investment in China that promise a better environment for overseas investment, drawing some relief for industry associations that consider recent policy moves as protectionist and that they say stifle cross-border innovation

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel